Nov 07, 2023 / 11:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Q2 FY '24 Earnings Conference Call of Alembic Pharmaceuticals Limited. We have with us today Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. R.K. Baheti, Director, Finance and CFO; Mr. Mitanshu Shah, Head of Finance; and Mr. Ajay Kumar Desai, Senior VP, Finance.
(Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. R.K. Baheti. Thank you, and over to you, Mr. R.K. Baheti.
Raj Kumar Shreeram Baheti - Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director
Thanks. Good evening, everyone. Thank you all for joining the second quarter results conference call. I'm sure you would have got the results by now. Let me, however, briefly take you through the numbers for the quarter ended 30th of September 2023.
During the quarter, our revenue grew by 8% to INR 1,595 crores. EBITDA is INR 218 crores, which is 14% of sales. And net profit is INR 137 crores. During H1, the revenue grew
Q2 2024 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Nov 07, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers